Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 3
2006 3
2010 5
2011 1
2012 1
2013 1
2016 2
2019 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Zoledronic acid.
Coleman R, Burkinshaw R, Winter M, Neville-Webbe H, Lester J, Woodward E, Brown J. Coleman R, et al. Among authors: neville webbe h. Expert Opin Drug Saf. 2011 Jan;10(1):133-45. doi: 10.1517/14740338.2011.540387. Epub 2010 Nov 29. Expert Opin Drug Saf. 2011. PMID: 21114419 Review.
Potential anticancer properties of bisphosphonates.
Neville-Webbe HL, Gnant M, Coleman RE. Neville-Webbe HL, et al. Semin Oncol. 2010 Jun;37 Suppl 1:S53-65. doi: 10.1053/j.seminoncol.2010.06.008. Semin Oncol. 2010. PMID: 20682373 Review.
Responding to Acute Care Needs of Patients With Cancer: Recent Trends Across Continents.
Young A, Marshall E, Krzyzanowska M, Robinson B, Brown S, Collinson F, Seligmann J, Abbas A, Rees A, Swinson D, Neville-Webbe H, Selby P. Young A, et al. Among authors: neville webbe h. Oncologist. 2016 Mar;21(3):301-7. doi: 10.1634/theoncologist.2014-0341. Epub 2016 Feb 26. Oncologist. 2016. PMID: 26921289 Free PMC article. Review.
The anti-tumour activity of bisphosphonates.
Neville-Webbe HL, Holen I, Coleman RE. Neville-Webbe HL, et al. Cancer Treat Rev. 2002 Dec;28(6):305-19. doi: 10.1016/s0305-7372(02)00095-6. Cancer Treat Rev. 2002. PMID: 12470981 Review.
The role of bisphosphonates in breast and prostate cancers.
Brown JE, Neville-Webbe H, Coleman RE. Brown JE, et al. Among authors: neville webbe h. Endocr Relat Cancer. 2004 Jun;11(2):207-24. doi: 10.1677/erc.0.0110207. Endocr Relat Cancer. 2004. PMID: 15163299 Review.
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Earl HM, Hiller L, Vallier AL, Loi S, McAdam K, Hughes-Davies L, Harnett AN, Ah-See ML, Simcock R, Rea D, Raj S, Woodings P, Harries M, Howe D, Raynes K, Higgins HB, Wilcox M, Plummer C, Mansi J, Gounaris I, Mahler-Araujo B, Provenzano E, Chhabra A, Abraham JE, Caldas C, Hall PS, McCabe C, Hulme C, Miles D, Wardley AM, Cameron DA, Dunn JA; PERSEPHONE Steering Committee and Trial Investigators. Earl HM, et al. Lancet. 2019 Jun 29;393(10191):2599-2612. doi: 10.1016/S0140-6736(19)30650-6. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178152 Free PMC article. Clinical Trial.
Cardiopulmonary exercise variables and their association with postoperative morbidity and mortality after major oesophagogastric cancer surgery-a multicentre observational study.
West MA, Rahman S, Jack S, Grocott MPW, Levett DZH; Perioperative Exercise Testing and Training Society (POETTS); Rashid Y, Griffiths J, Ezra M, Ayres L, Neville-Webbe H, Javed MS, Shrotri M, Khan I, Whitmore D, Prabhu P, Timbrell D, Allen S, Packham AO, Sharpe D, Anderson H, Minto G, McAleer S, McPhail S, Alasmar M, Hartley RA, Sultan J, Grace B, Underwood TJ, Byrne J, Noble F, Kelly J, Ansell G, Edwards M. West MA, et al. Among authors: neville webbe h. BJA Open. 2024 Jun 7;10:100289. doi: 10.1016/j.bjao.2024.100289. eCollection 2024 Jun. BJA Open. 2024. PMID: 38947220 Free PMC article.
22 results